BioWorld: COVID-19 drug development: Optimizing activity during the worst of times

At the best of times, drug development is, of course, a complex problem. It is all the more demanding still in the middle of a pandemic, when the threat to human life is increasing exponentially, and health care systems are buckling under an extraordinary burden. Optimizing the development of drugs and vaccines in order to quickly generate high-quality evidence of their safety and efficacy is, therefore, a critical task…

Author(s): Cormac Sheridan

返回顶部
Powered by Translations.com GlobalLink OneLink Software